[ad_1]
Washington Agencies
The US Food and Drug Administration (FDA) has approved a new drug for the treatment of cancer in adults and children, based on genetic mutations rather than the type of disease.
The drug called Vitrakvi Vitrakvi has been approved for the treatment of cancers that occur anywhere in the body.
NITCAVI is the first drug designed from the start to fight the genetic mutation of the disease, regardless of the type of cancer, said NBC.
FDA approval is an important step in the treatment of cancer, "FDA Commissioner Scott Gottlieb said in a statement. The base of the genes of the tumor, whatever their origin in the body. "
"It will help patients get" fast treatment, "he said.
Source link
